Kezar Life Sciences
123 hedge funds and large institutions have $401M invested in Kezar Life Sciences in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 55 increasing their positions, 42 reducing their positions, and 19 closing their positions.
Holders
123
Holders Change
-9
Holders Change %
-6.82%
% of All Funds
1.98%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
10
Increased
55
Reduced
42
Closed
19
Calls
$1.49M
Puts
$27K
Net Calls
+$1.47M
Net Calls Change
-$6.49M
Top Buyers
1 |
O
1
OrbiMed
New York
|
$32.3M |
2 |
DM
2
Deerfield Management
New York
|
$10.1M |
3 |
APM
3
Avidity Partners Management
Dallas,
Texas
|
$47.7M |
4 |
4
State Street
Boston,
Massachusetts
|
$29.9M |
5 |
NHAS
5
Novo Holdings A/S
Hellerup,
Denmark
|
$8.27M |